NEW! AMLEXIN®: An innovative solution for Cartilage Protection

We are pleased to add Amlexin® to our current Unigen range which is approved for the European market.

Amlexin® is a plant-based composition that contains a proprietary combination of Acacia catechu heartwood extract and Morus alba root bark extract, which in human clinical trials, has demonstrated the ability to help protect cartilage from breaking down. In a study, 135 participants (aged 35 to 75 years), who had symptoms of knee discomfort, were supplemented with 400 mg/day of AmLexin® and an active comparator (Glucosamine: 1500 mg and Chondroitin: 1200 mg combination per day) for 12 weeks vs placebo group.¹

Participants in the AmLexin® group showed an 8.9% reduction in the uCTX-II while there was a 25.1% increase in the uCTX-II level for the placebo group.

According to research AmLexin®, as a protective approach for joint cartilage breakdown, has shown to be effective in an ex vivo GAG assay, at reducing Glycosaminoglycan (GAG) released by articular cartilage.

Discover more by visiting our AmLexin® dedicated page or contact us.

_References:

_{(1) Kalman DS, Hewlings SJ. The Effects of Morus albaand Acacia catechuon Quality of Life and Overall Function in Adults with Osteoarthritis of the Knee. J Nutr Metab. 2017;2017:4893104. doi: 10.1155/2017/4893104. Epub 2017 Sep 11. PMID: 29085676; PMCID: PMC5612321}